RB1CC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.808200E-01
Normal-vs-Stage2
8.592800E-01
Normal-vs-Stage3
1.944070E-02
Normal-vs-Stage4
8.981400E-01
Stage1-vs-Stage2
7.786200E-01
Stage1-vs-Stage3
1.304020E-01
Stage1-vs-Stage4
9.049600E-01
Stage2-vs-Stage3
1.629210E-01
Stage2-vs-Stage4
6.970200E-01
Stage3-vs-Stage4
1.869410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.260200E-01
Normal-vs-AfricanAmerican
7.739600E-01
Normal-vs-Asian
6.024400E-01
Caucasian-vs-AfricanAmerican
4.567000E-01
Caucasian-vs-Asian
4.439800E-01
AfricanAmerican-vs-Asian
3.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.681600E-01
Normal-vs-Female
9.082800E-01
Male-vs-Female
7.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.591200E-01
Normal-vs-Age(41-60Yrs)
7.539400E-01
Normal-vs-Age(61-80Yrs)
7.566000E-01
Normal-vs-Age(81-100Yrs)
6.255000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.896800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.525600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.894400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.250100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.142650E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.015200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.575000E-01
Normal-vs-Daily Drinker
7.253800E-01
Normal-vs-Weekly Drinker
5.919600E-01
Normal-vs-Occasional Drinker
8.892600E-01
Normal-vs-Social Drinker
9.426800E-01
Non Drinker-vs-Daily Drinker
6.705200E-01
Non Drinker-vs-Weekly Drinker
7.322800E-01
Non Drinker-vs-Occasional Drinker
2.064600E-01
Non Drinker-vs-Social Drinker
1.666420E-01
Daily Drinker-vs-Weekly Drinker
9.409800E-01
Daily Drinker-vs-Occasional Drinker
3.813200E-01
Daily Drinker-vs-Social Drinker
4.476600E-01
Weekly Drinker-vs-Occasional Drinker
3.425200E-01
Weekly Drinker-vs-Social Drinker
3.849200E-01
Occasional Drinker-vs-Social Drinker
8.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.618600E-01
Normal-vs-Grade 2
1.651410E-01
Normal-vs-Grade 3
2.015800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.819600E-01
Grade 1-vs-Grade 3
2.182400E-01
Grade 1-vs-Grade 4
3.618600E-01
Grade 2-vs-Grade 3
3.286600E-01
Grade 2-vs-Grade 4
1.651410E-01
Grade 3-vs-Grade 4
2.015800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.275400E-01
Normal-vs-NonDiabetic
7.844200E-01
Diabetic-vs-NonDiabetic
8.733200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.855000E-01
Normal-vs-NoPancreatitis
8.029600E-01
Pancreatitis-vs-NoPancreatitis
8.265600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.266000E-01
Normal-vs-N1
8.856200E-01
N0-vs-N1
9.395400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.731000E-01
Normal-vs-TP53-NonMutant
8.508400E-01
TP53-Mutant-vs-TP53-NonMutant
1.097820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
